NANO MRNA Co.,Ltd. Logo

NANO MRNA Co.,Ltd.

Biotech IP generator developing and licensing mRNA therapeutics using proprietary delivery systems.

4571 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
港区愛宕二丁目5番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

NANO MRNA Co., Ltd. is a biotechnology company specializing in the research and development of mRNA-based therapeutics and other nucleic acid medicines. Operating under an "IP Generator" business model, the company functions as a platform connecting drug discovery seeds with medical and development needs. Its core strategy involves creating intellectual property for novel therapies and then licensing them out to pharmaceutical partners for further development and commercialization. NANO MRNA leverages proprietary Drug Delivery System (DDS) technologies to advance its pipeline, which includes candidates for indications such as osteoarthritis and glioblastoma. Formerly Nanocarrier Co., Ltd., the company has repurposed its extensive R&D experience to focus on mRNA drug discovery. In addition to its R&D activities, the company also markets co-developed pharmaceutical products.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for NANO MRNA Co.,Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-18 08:30
Regulatory News Service
臨時報告書
Japanese 28.4 KB
2025-07-01 08:30
Regulatory News Service
臨時報告書
Japanese 25.9 KB
2025-06-30 08:33
Regulatory News Service
内部統制報告書-第29期(2024/04/01-2025/03/31)
Japanese 22.8 KB
2025-06-30 08:31
Regulatory News Service
確認書
Japanese 8.1 KB
2025-06-30 08:30
Annual Report
有価証券報告書-第29期(2024/04/01-2025/03/31)
Japanese 906.3 KB
2025-05-14 08:34
Regulatory News Service
臨時報告書
Japanese 18.7 KB
2025-02-14 07:38
Regulatory News Service
臨時報告書
Japanese 18.8 KB
2024-11-18 07:32
Regulatory News Service
臨時報告書
Japanese 18.6 KB
2024-11-14 07:03
Regulatory News Service
確認書
Japanese 8.1 KB
2024-11-14 07:02
Interim Report
半期報告書-第29期(2024/04/01-2025/03/31)
Japanese 169.1 KB
2024-07-01 08:07
Regulatory News Service
臨時報告書
Japanese 22.2 KB
2024-06-28 08:06
Regulatory News Service
内部統制報告書-第28期(2023/04/01-2024/03/31)
Japanese 22.1 KB
2024-06-28 08:05
Regulatory News Service
確認書
Japanese 8.5 KB
2024-06-28 08:01
Annual Report
有価証券報告書-第28期(2023/04/01-2024/03/31)
Japanese 922.0 KB
2024-02-14 07:05
Regulatory News Service
確認書
Japanese 8.5 KB

Automate Your Workflow. Get a real-time feed of all NANO MRNA Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for NANO MRNA Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
PharmaLundensis AB Logo
Develops treatments for heavy metal toxicity and serious respiratory illnesses.
Sweden PHAL
PhoenixBio Co.,Ltd. Logo
CRO providing humanized liver mouse models and testing services for preclinical drug development.
Japan 6190
Plantarc Bio Ltd. Logo
Developing high-yield, resilient crops via gene discovery for global seed companies.
Israel PLNT
Polymetal International plc Logo
A top global gold and silver producer with mining and exploration operations in Kazakhstan.
Kazakhstan POLY
Poxel Logo
Develops drugs for metabolic diseases, including NASH, rare diseases, and an approved diabetes drug.
France POXEL
PRAP Japan,Inc. Logo
A PR & communications firm building brand reputation for corporate clients in diverse industries.
Japan 2449
Public Policy Holding Company, Inc. Logo
Advisory group providing public policy, government relations, and strategic communications services.
United States of America PPHC.L
Purple Biotech Ltd. Logo
Developing cancer therapies to overcome tumor immune evasion and drug resistance.
Israel PPBT
QUIA PHARMA AB Logo
Develops biobetters by enhancing approved drugs with a patented drug delivery platform.
Sweden QUIA
RaQualia Pharma Inc. Logo
An R&D firm discovering novel small molecules for out-licensing to pharma partners.
Japan 4579

Talk to a Data Expert

Have a question? We'll get back to you promptly.